Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rob J W Berg"'
Autor:
André M. M. Miltenburg, Marita Prohn, Renger G. Tiessen, Jacqueline H. M. van Kuijk, Martin de Kort, Rob J. W. Berg
Publikováno v:
British Journal of Clinical Pharmacology. 75:1221-1230
Aim Conjugation to antithrombin III ATIII-binding pentasaccharides has been proposed as a novel method to extend the half-life of therapeutic proteins. We aim to validate this technological concept in man by performing a first-in-human study using Ca
Autor:
André M. M. Miltenburg, Jolanda H.G.M. Brands, C. Marco Timmers, Ralf Plate, Rob J W Berg, Willem-Jan Karstens, J. Robert Lane, Paolo Conti, Tanja A.E. van Achterberg, Monique G.A. van Amstel, Marcel E. de Gooyer, Chris J. van Koppen, Jesse W.Y. Wat
Publikováno v:
British Journal of Pharmacology. 165:2314-2324
BACKGROUND AND PURPOSE Graves' disease (GD) is an autoimmune disease in which the thyroid is overactive, producing excessive amounts of thyroid hormones, caused by thyroid-stimulating hormone (TSH) receptor-stimulating immunoglobulins (TSIs). Many GD
Autor:
Rob J. W. Berg
Publikováno v:
Encyclopedia of Cancer ISBN: 9783642278419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4c1e1319f4f75aba25311d1214fc600
https://doi.org/10.1007/978-3-642-27841-9_6280-2
https://doi.org/10.1007/978-3-642-27841-9_6280-2
Autor:
Marjan L. F. Jagt-Smook, Steven Ramael, Justin Dennie, Pierre A. M. Peeters, Michiel W. van den Heuvel, Pieter-Jan de Kam, Rob J. W. Berg, Guy Cammu, Peter Grobara
Publikováno v:
Clinical drug investigation. 33(8)
We evaluated the potential for QT/corrected QT (QTc) interval prolongation after sugammadex given with propofol or sevoflurane anaesthesia. This was a two-factorial, randomized, parallel-group study in 132 healthy subjects. Anaesthesia was maintained
Autor:
André M M, Miltenburg, Marita, Prohn, Jacqueline H M, van Kuijk, Renger G, Tiessen, Martin, de Kort, Rob J W, Berg
Publikováno v:
British journal of clinical pharmacology. 75(5)
Conjugation to antithrombin III ATIII-binding pentasaccharides has been proposed as a novel method to extend the half-life of therapeutic proteins. We aim to validate this technological concept in man by performing a first-in-human study using CarboC
Autor:
Rob J. W. Berg
Publikováno v:
Journal of Investigative Dermatology. 110:405
Autor:
Frank R. de Gruijl, Rob J. W. Berg
Publikováno v:
Photochemistry and Photobiology. 68:555